Skip to main content

LAP Lambert Academic Publishing

Ticagrelor Versus Clopidogrel in Prevention of No Reflow

No reviews yet
Product Code: 9786208064211
ISBN13: 9786208064211
Condition: New
$77.00
$75.39
Sale 2%

Ticagrelor Versus Clopidogrel in Prevention of No Reflow

$77.00
$75.39
Sale 2%
 
Adequacy of coronary flow can be judged upon using several methods like TIMI Grade and myocardial blush grade. No-reflow phenomenon, defined as incomplete reperfusion at the microvascular level despite adequate patency of the occluded artery, remains an important limitation of primary percutaneous intervention in STEMI patients nowadays. We aim in this study to investigate the relationship between the antiplatelet loading dose whether to be Ticagrelor or Clopidogrel and post intervention coronary flow, bleeding risk in these patients.Aim of the Work: To compare between the effects of preoperative loading dose of Ticagrelor and clopidogrel in Diabetic STEMI patients undergoing primary percutaneous coronary intervention regarding prevention of no reflow, Instent thrombosis and short term bleeding risk. Myocardial reperfusion was judged upon using TIMI Grade and myocardial blush grade.


Author: Mohamed Gamal Elshawa
Publisher: LAP Lambert Academic Publishing
Publication Date: Sep 02, 2024
Number of Pages: 132 pages
Binding: Paperback or Softback
ISBN-10: 620806421X
ISBN-13: 9786208064211
 

Customer Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Faster Shipping

Delivery in 3-8 days

Easy Returns

14 days returns

Discount upto 30%

Monthly discount on books

Outstanding Customer Service

Support 24 hours a day